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Objectives. This study attempted to determine the importance 
of severe proximal right coronary artery disease as a predictor of 
atrial fibrillation in patients after coronary artery bypass urgery. 
Background. Studies in patients undergoing noncardiac sur- 
gery have suggested that ischemia in the right coronary artery 
distribution is associated with a high incidence of atrial fibrilla- 
tion. However, the importance of fight coronary artery disease as 
a predictor of atrial fibrillation after bypass urgery is unknown. 
Methods. The occurrence of sustained postoperative atrial 
fibrillation was studied prospectively in 168 consecutive patients 
undergoing coronary artery bypass grafting. Patients were fol. 
lowed up postoperatively until discharge. Severe right coronary 
artery stenosis was defined as >70% lumen narrowing. 
Results. Of 104 patients with proximal or mid right coronary 
artery stenosis, 45 (43%) had atrial fibrillation postoperatively 
compared with 12 (19%) of the 64 patients without significant 
right coronary disease (p = 0.001). Univariate predictors of atrial 
fibrillation included right coronary artery stenosis (p = 0.001), 
advancing age (p = 0.0001) and lack of beta-adrenergic blocking 
agent therapy after bypass surgery (p = 0.0004). Multivariate 
adjusted risk of developing atrial fibrillation after bypass urgery 
increased with the presence of severe right coronary artery disease 
(odds ratio 3.69, 95% confidence interval [CI] 1.61 to 8.48), 
advancing age (odds ratio 2.24/10 years, CI 1.48 to 3.41) and male 
gender (odds ratio 2.36, CI 1.01 to 5.49). The use of beta-blockers 
postoperatively was associated with a protective ffect (odds ratio 
0.4, CI 0.17 to 0.80). 
Conclusions. The presence of severe right coronary artery 
stenosis is an independent and powerful predictor of atrial 
fibrillation after coronary artery bypass surgery. In association 
with age, gender and postoperative beta-blocker therapy, these 
variables can be used to identify patients at increased risk for 
developing this arrhythmia. 
(J Am CoU Cardiol 1995;25:198-202) 
Atrial fibrillation is a frequent complication after coronary 
artery bypass grafting, occurring in up to 40% of patients 
(1-6). Although this arrhythmia isusually benign, it may result 
in hemodynamic compromise, thromboemboli and an increase 
in the hospital length of stay (3,6-9). In addition, treatment of 
atrial fibrillation may be associated with potentially harmful 
side effects. 
Although atrial fibrillation after coronary bypass surgery 
has been widely studied, there is little agreement as to the 
pathogenesis of this arrhythmia. Clinical features that have 
been identified as predictors of atrial fibrillation include ad- 
vancing age and lack of postoperative b ta-adrenergic blocking 
agent therapy (3,4). However, in a large number of patients 
who develop atrial fibrillation, no apparent risk factor can be 
identified (2,6). In previous studies (3,4,10) the extent and 
location of coronary artery disease has not been independently 
predictive of atrial fibrillation after bypass urgery, but limited 
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information has suggested that concomitant right coronary 
endarterectomy may predispose to this arrhythmia. Other 
studies (11-13) of patients undergoing noncardiac surgery 
have suggested that ischemia in the right coronary artery 
distribution is also associated with a high incidence of atrial 
fibrillation. However, the importance of severe right coronary 
artery disease as a predictor of postoperative atrial fibrillation 
has not been previously evaluated. 
To assess this further, patients undergoing elective coronary 
artery bypass urgery were prospectively followed up to deter- 
mine the impact of severe proximal right coronary artery 
disease on the incidence of postoperative atrial fibrillation. 
These data, in combination with other perioperative variables, 
were used to identify patients who were at highest risk for 
developing atrial fibrillation after bypass urgery. 
Methods  
Study patients. One hundred sixty-eight consecutive pa- 
tients undergoing a first coronary artery bypass graft surgery 
were studied prospectively for the occurrence of postoperative 
atrial fibrillation. Exclusion criteria included previous history 
of atrial fibrillation and use of antiarrhythmic agents, with the 
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exception of digoxin and beta-blockers. No patient had signif- 
icant valve disease requiring surgical intervention. 
All patients had undergone coronary angiography within 
1 month of bypass urgery. Significant right coronary artery 
disease was defined as ->70% lumen diameter narrowing of the 
proximal or mid segment. Left ventricular function was as- 
sessed by single-plane ventriculography. All angiograms were 
read by an experienced invasive cardiologist before bypass 
surgery. 
Surgical technique. Coronary artery bypass surgery was 
performed by one of four cardiothoracic surgeons using stan- 
dard techniques. After the initiation of cardiopulmonary b - 
pass, cardiac arrest was achieved using cold cardioplegia. The 
delivery of cardioplegia was by anterograde or a combination 
of anterograde and retrograde perfusion. Myocardial preser- 
vation was maintained by topical cold saline solution. Systemic 
hypothermia was maintained at 28°C. Conduits for bypass 
included the saphenous veins or internal mammary artery, or a 
combination of the two. All patients with significant right 
coronary artery disease underwent bypass. No patient under- 
went endarterectomy of the proximal or mid right coronary 
artery. 
Clinical evaluation. All patients had continuous electro- 
cardiographic (ECG) telemetry monitoring (Hewlett-Packard 
78510B) for the first 6 postoperative days and, in most patients, 
until hospital discharge. All stored alarms were reviewed aily 
by an experienced cardiologist. Sustained atrial fibrillation was 
defined as an episode lasting >30 rain. All atrial fibrillation 
identified on the monitor was confirmed by a 12-lead ECG. 
The day of onset and the use of beta-blocker therapy before 
onset of the arrhythmia were noted. Hospital stay was defined 
as the total number of days that the patient was hospitalized 
from the day of surgery. 
The relation of atrial fibrillation to several perioperative 
variables was also evaluated. The preoperative ariables exam- 
ined included age; gender; presence of diabetes, hypertension 
or chronic obstructive pulmonary disease; coronary anatomy 
and dominance; left ventricular end-diastolic pressure at time 
of angiography; left ventricular ejection fraction; and urgency 
of operation. Intraoperative ariables included aortic cross- 
clamp time, pump time, route of cardioplegia nd number of 
distal anastomoses. Postoperative variables included peak cre- 
atinine kinase (CK) level (U/liter); frequency and dose of 
vasopressors; ight- and left-sided cardiac pressures; and prev- 
alence of hypotension, hypoxia and acidosis. In addition, 
postoperative complications, including new Q wave myocardial 
infarction, stroke, thoracic reexploration and death, were 
identified. 
Statistical analysis. Patients were grouped according to 
the presence or absence of right coronary artery disease and 
development of postoperative atrial fibrillation. Mean values 
and standard errors were compared for continuous variables 
and percents for categoric variables. Initial comparisons be- 
tween groups were made using a Student t test for continuous 
measures and the chi-square test for categoric variables. 
Independent predictors of atrial fibrillation were determined 
Table 1. Clinical Characteristics of Patients With and Without 
Significant Right Coronary Artery Disease 
Without 
With RCA RCA p 
(n = 104) (n = 64) Value 
Age (yr) 65.8 _+ 1.0 63.6 _+ 1.3 0.2 
Male gender 67 (64%) 46 (72%) 0.4 
HBP 63 (61%) 34 (52%) 0.4 
COPD 11 (11%) 10 (15%) 0.5 
LVEF (%) 55.8 _+ 1.5 58.3 +_ 1.6 0.3 
No. of grafts 3.3 -- 0.1 3.3 + 0.1 1.0 
Clamp time (min) 40.5 _+ 1.1 39.7 _+ 1.6 0.7 
Pump time (rain) 88.4 _+ 2.0 85.6 +_ 3.1 0.4 
CK (U/liter) 1,109 +_ 103 1,408 + 175 0.1 
Beta-blocker post-op 77 (74%) 49 (77%) 0.9 
AF 45 (43%) 12 (19%) 0.001 
Data presented are mean value -- SEM or number (%) of patients. AF = 
atrial fibrillation; CK = creatinine kinase; COPD = chronic obstructive pulmo- 
nary disease; HBP = high blood pressure; LVEF = left ventricular ejection 
fraction; post-op = postoperatively; RCA - right coronary artery. 
by using a stepwise logistic regression analysis that included the 
following variables: age; gender; hypertension; diabetes; 
chronic lung disease; coronary anatomy, including right coro- 
nary artery stenosis; beta-blocker therapy; number of distal 
anastomoses; and clamp and pump times. A p value < 0.05 was 
considered statistically significant. 
Resu l ts  
Sustained atrial fibrillation occurred in 57 (33.9%) of the 
168 patients a mean of 3.4 _+ 0.2 days after coronary artery 
bypass urgery (range 1 to 7). The clinical characteristics of the 
patients with and without significant right coronary artery 
disease are compared in Table 1. There were no significant 
differences between the two groups with respect o gender; left 
ventricular ejection fraction; or previous history of diabetes, 
hypertension rchronic lung disease. The duration of cardio- 
pulmonary bypass and aortic cross-clamping, delivery of car- 
dioplegia and number of distal anastomoses did not differ 
between the two groups. Peak CK levels and postoperative 
beta-blocker therapy were also similar. The only variable that 
differed significantly between the two groups was the frequency 
of atrial fibrillation. Of 104 patients with significant right 
coronary artery disease, 45 (43%) had postoperative atrial 
fibrillation compared with 12 (19%) of the 66 patients without 
disease in this vessel (p = 0.001), a 2.4-fold increase in the 
incidence of atrial fibrillation. 
The contribution of right coronary artery disease is further 
shown in Table 2 in which patients were stratified according to 
the occurrence of atrial fibrillation. Right coronary artery 
disease was present in 45 (79%) of the 57 patients with atrial 
fibrillation compared with 59 (53 %) of the 111 patients without 
atrial fibrillation (p = 0.001). Patients with postoperative atrial 
fibrillation were also significantly older (p = 0.0001) and less 
likely to have beta-blocker therapy after bypass urgery (p -- 
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Table 2. Clinical Characteristics of Patients Stratified According to 
Occurrence of Atrial Fibrillation 
With AF Without AF p 
(n = 57) (n - 111) Value 
Age (yr) 69.7 + 1.2 62.1 ± 1.0 0.0001 
Male gender 41 (72%) 72 (65%) 0.5 
HBP 35 (61%) 62 (56%) 0.6 
COPD 10 (18%) 11 (10%) 0.2 
LVEF (%) 56.7 + 1.8 56.3 +_ 1.4 0.9 
RCA stenosis 45 (79%) 59 (53%) 0.001 
No. of grafts 3.3 _+ 0.1 3.3 + 0.1 1.0 
Clamp time (rain) 38.7 _+ 1.5 40.6 _+ 1.2 0.3 
Pump time (min) 84.5 + 2.9 88.0 _+ 2.2 0.2 
Peak CK (U/liter) 1,009 _+ 135 1,255 -+ 12.1 0.2 
Beta-blocker post-op 29 (51%) 87 (78%) 0.0004 
Data presented are mean value _+ SEM or number (%) of patients. 
Abbreviations a in Table 1. 
0.0004). Hospital stay was also significantly longer in patients 
with (10.1 _+ 0.6 days) than without (8.3 + 0.4 days) atrial 
fibrillation (p = 0.02). 
There were no other significant clinical, angiographic or 
hemodynamic differences between the two groups. The inci- 
dence of postoperative stroke, thoracic reexploration and Q 
wave myocardial infarction in patients with and without atrial 
fibrillation was 4%, 5% and 5% and 2%, 1% and 5%, 
respectively. One patient died 3 days after bypass surgery 
secondary to sudden intractable ventricular arrhythmia. Atrial 
fibrillation had not occurred before this event. 
A stepwise logistic regression analysis was performed to 
identify which clinical variables were independent predictors of 
atrial fibrillation after coronary bypass surgery (Table 3). 
Advancing age was the most powerful predictor of postopera- 
tive atrial fibrillation (p = 0.0002), with a 2.2-fold increase for 
every 10-year increase in age. Similarly, the presence of 
proximal right coronary artery disease was also an important 
predictor (p = 0.002), with the odds of postoperative atrial 
fibrillation 3.7 times more likely in patients with than without 
right coronary artery stenosis. There was also a weak associa- 
tion between atrial fibrillation and gender, with men having 2.4 
times the odds of developing postoperative atrial fibrillation as 
women (p = 0.05). By contrast, the use of postoperative 
beta-blockers had a protective ffect such that patients treated 
with beta-blockers had 0.4 times the odds of developing 
postoperative atrial fibrillation as those untreated (p = 0.01). 
Table 3. Multivariate Analysis of Predictors of Atrial Fibrillation 
After Coronary Artery Bypass Graft Surgery 
Unit Odds p 
Variable Increase Ratio Value 95% CI 
Age (yr) 10 2.2 0.0002 1.48-3.41 
RCA stenosis 1 3.7 0.002 1.61-8.48 
Beta-blocker post-op 1 0.4 0.01 0.17- 0.80 
Male gender 1 2.4 0.05 1.01-5.49 
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Figure 1. Graphic representation f the logistic regression equation 
depicting the risk of atrial fibrillation (AF) in all patients tratified 
according to age, right coronary artery disease and postoperative 
beta-blocker therapy. Thick solid line = right coronary artery disease 
and no beta-blocker therapy; thick dotted line = right coronary artery 
disease and beta-blocker therapy; thin solid line = no right coronary 
artery disease and no beta-blocker therapy; thin dotted line = no right 
coronary artery disease and beta-blocker therapy. 
Although male gender was an independent risk factor for this 
arrhythmia, the effects of right coronary artery disease and 
beta-blocker therapy on the development of atrial fibrillation 
after bypass urgery were similar for both men and women. 
The logistic regression equation is represented graphically 
in Figures 1 and 2 and depicts the relation among the four 
independent variables of postoperative atrial fibrillation. In 
Figure 1 patients were stratified according to the presence of 
right coronary artery disease and postoperative b ta-blocker 
therapy. As depicted by Figure 1, the incidence of atrial 
fibrillation increased in all four groups with advancing age. 
However, patients with proximal right coronary artery stenosis 
without postoperative b ta-blocker had the highest occurrence 
of atrial fibrillation, with the risk ranging from <20% in 
patients -<40 years old to >70% in those ->70 years old. 
Postoperative beta-blockers did offer some protection in the 
high risk older patients with right coronary disease such that 
Figure 2. Graphic representation f the logistic regression equation 
depicting the risk of atrial fibrillation (AF) in patients with right 
coronary artery disease according to age, gender and postoperative 
beta-blocker therapy. Thick solid line = men without beta-blocker 
therapy; thin solid line = women without beta-blocker therapy; thick 
dotted line = men with beta-blocker therapy; thin dotted line = 
women with beta-blocker therapy. 
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the incidence of atrial fibrillation in this group was similar to 
that of patients without right coronary artery stenosis not 
treated with a beta-blocker. The lowest risk patients were those 
without proximal right coronary artery disease who were 
treated with a postoperative b ta-blocker. The risk of atrial 
fibrillation in this group at age 70 was only 19%. 
Figure 2 depicts the risk of atrial fibrillation in patients with 
right coronary artery stenosis according to gender and postop- 
erative beta-blocker therapy. The risk of developing atrial 
fibrillation at any age was highest for men without beta-blocker 
therapy, with a predicted risk ranging from <20% in men _<40 
years old to >70% in those >70 years old. Men with and 
women without postoperative beta-blocker therapy had a 
nearly equal risk of developing atrial fibrillation, with an 
incidence of -50% at age 70 years. Women with beta-blocker 
therapy had the lowest risk of postoperative atrial fibrillation, 
with a 30% chance of arrhythmia occurrence at 70 years of age. 
Despite the powerful effect of age on the incidence of atrial 
fibrillation after bypass surgery, these data show that the 
presence of proximal right coronary artery disease and the lack 
of postoperative b ta-blocker therapy remain important risk 
factors for the development of atrial fibrillation. 
The effect of the four variables independently predictive of 
postoperative atrial fibrillation may be represented by the 
following equation and reflects the probability of developing 
this arrhythmia: 
Probability of atrial fibrillation = eU/1 + e u, 
where u = -6.8428 + 0.0808(Age) + 0.8587(Gender) - 
0.9894(Beta-blocker therapy) + 1.3069(Right coronary artery 
stenosis). 
For Figure 1, gender = 0.673, which is the proportion of 
men in the study. For Figure 2, gender = 1 for men and 0 for 
women. Beta-blocker therapy = 1 if used after surgery and 
before onset of atrial fibrillation, if it occurred, and 0 if not 
used or started after the initiation of atrial fibrillation. Right 
coronary artery stenosis = 1 if present and 0 if not present. 
Discuss ion  
Atrial fibrillation is one of the most common arrhythmias 
complicating coronary artery bypass urgery, with a reported 
incidence of up to 40% (1-6). Despite the frequent occurrence 
of atrial fibrillation after cardiac surgery, little is known about 
the pathogenesis ofthis arrhythmia. In the present prospective 
study, risk factor analysis identified the presence of severe 
proximal right coronary artery disease as an independent and 
powerful predictor of atrial fibrillation after bypass urgery, an 
observation that has not been previously demonstrated. In 
addition, and consistent with previous studies, age, male 
gender and lack of postoperative b ta-blocker therapy also 
proved to be important determinants of postoperative atrial 
fibrillation. Using these predictors in combination, subgroups 
of patients with a high risk of developing atrial fibrillation after 
coronary artery bypass surgery can be identified. Elderly 
patients with significant right coronary artery disease were at 
highest risk for atrial fibrillation after bypass urgery, with men 
being more predisposed to this arrhythmia than women. 
Despite the high risk of postoperative atrial fibrillation in these 
groups with right coronary artery disease, postoperative b ta- 
blocker therapy remained an effective means of reducing the 
frequency of this arrhythmia n both men and women and in 
the older age groups. 
Previous studies. Few studies in the past have used risk 
factor analysis to predict which patients are at high risk for 
developing atrial fibrillation after bypass urgery (3,4,6,14). In 
a large study by Fuller et al. (3), the relation between postop- 
erative atrial fibrillation and 25 perioperative variables was 
evaluated in patients undergoing bypass urgery. Multivariate 
regression analysis revealed that the strongest independent 
predictors of postoperative atrial fibrillation were advancing 
age (p = 0.0001), lack of postoperative b ta-blocker therapy 
(p = 0.001) and male gender (p = 0.02). In a similar analysis, 
Leitch et al. (4) found that in patients undergoing coronary 
artery bypass graft surgery at their institution, age was the most 
important predictor of atrial fibrillation, with a 1.7-fold in- 
crease in the risk of atrial fibrillation for every 10-year incre- 
mental increase in age. Other variables that had an indepen- 
dent influence on the development of atrial fibrillation 
included obstructive pulmonary disease (p = 0.006) and 
chronic renal disease (p = 0.04). Patients were not stratified 
according to the presence of right coronary artery disease in 
either of these studies. However, Caretta et al. (14) found that 
of 236 consecutive patients undergoing coronary artery bypass, 
the presence of right coronary artery occlusion in combination 
with proximal left anterior descending coronary artery stenosis 
was not a risk factor for atrial fibrillation. In that study only a 
prolonged cross-clamp time was associated with postoperative 
atrial fibrillation. 
The protective ffect of beta-blocker therapy after bypass 
surgery has been demonstrated by several studies (6,15,16). 
Rubin et al. (6) demonstrated that of 123 patients undergoing 
coronary artery bypass urgery, 16.2% of patients treated with 
propranolol developed postoperative atrial fibrillation com- 
pared with 37.5% of control patients (p < 0.03). Although 
patients with atrial fibrillation were older than patients without 
this arrhythmia, this difference did not reach statistical signif- 
icance. Another agent hat may also be effective in preventing 
atrial fibrillation is sotalol (17,18). In a study by Nystrom et al. 
(18), 101 patients undergoing coronary artery bypass grafting 
were randomized to receive sotalol or another beta-blocker. 
The incidence of atrial fibrillation was 10% in the sotalol group 
compared with 29% in the other beta-blocker group (p = 
0.03). Similar to previous tudies, older age was also a predic- 
tor of postoperative atrial fibrillation. In neither of these two 
studies (6,18) was the importance of right coronary artery 
disease to the incidence of postoperative atrial fibrillation 
evaluated. 
Potential mechanism. In the present study the mechanism 
by which proximal right coronary artery stenosis may predis- 
pose to atrial fibrillation remains unknown. Previous studies 
have suggested that intraoperative ischemia in the right coro- 
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nary distribution may be important in the pathogenesis of this 
arrhythmia. In patients undergoing bypass urgery, concomi- 
tant right coronary endarterectomy has been associated with a 
high incidence of postoperative atrial arrhythmias (10). Patti- 
son et al. (10) found that in 200 patients undergoing coronary 
artery bypass surgery, the incidence of supraventricular - 
rhythmias, the majority of which were atrial fibrillation, was 
32% in patients undergoing both bypass surgery and right 
coronary endarterectomy butonly 19.8% in patients undergo- 
ing bypass urgery alone. These investigators suggested that 
ischemia secondary to endarterectomy ay be the reason for 
this observation. 
In studies unrelated to cardiac surgery, atrial fibrillation has 
been associated with right atrial and right ventricular infarc- 
tions accompanying an acute myocardial infarction. Several 
investigators (11,12) have reported that supraventricular - 
rhythmias, especially atrial fibrillation, are the most frequent 
ECG abnormality associated with atrial infarctions. In addi- 
tion, the majority of these infarctions appear to be localized to 
the right atrium and are frequently associated with proximal 
right coronary artery disease (11,12). Similarly, ischemia re- 
sulting in right ventricular dysfunction may also play a role in 
the pathogenesis of atrial fibrillation. Rechavia et al. (13) 
found that the presence of reduced right ventricular systolic 
function in patients with a first inferior myocardial infarction 
was an independent predictor of atrial fibrillation during the 
first 24 h of infarction. Potential mechanisms to explain this 
finding included concomitant right atrial infarction or an 
increase in right atrial pressure or size secondary to elevated 
right ventricular filling pressures. Unlike atrial fibrillation 
associated with an acute myocardial infarction, the peak 
incidence of atrial fibrillation after coronary artery bypass 
grafting is usually 48 to 72 h after operation, suggesting that in 
addition to right coronary artery disease, other factors are 
important in the pathogenesis of this arrhythmia. The mecha- 
nism by which right coronary artery disease may predispose to 
postoperative atrial fibrillation will require further periopera- 
tive investigation. 
Clinical implications. The importance of proximal right 
coronary artery disease as an additional risk factor for postop- 
erative atrial fibrillation is further highlighted by its association 
with a prolonged hospital stay (10.1 _+ 0.6 vs. 8.4 _+ 0.4 days, 
p = 0.02). Although further studies are necessary to determine 
whether atrial fibrillation is a causal or confounding factor, this 
observation does suggest hat prevention of this arrhythmia 
may impact hospital stay and costs. Risk stratification of 
patients undergoing bypass urgery may help to identify those 
patients most likely to benefit from prophylactic therapy. 
Whether the prevention of atrial fibrillation will impact hospi- 
tal stay and costs will need to be studied further by controlled 
trials. 
Conclusions. We believe that this is the first study to 
identify right coronary artery stenosis as a risk factor for atrial 
fibrillation after coronary artery bypass grafting. Additional 
independent and additive predictors are advancing age, male 
gender and lack of postoperative b ta-blocker therapy. This 
study also confirms that beta-blockers educe the incidence of 
atrial fibrillation after bypass urgery. Whether such therapy 
will be beneficial in all risk groups has yet to be determined by 
future controlled trials. However, even a modest reduction in 
the incidence of atrial fibrillation after coronary artery bypass 
surgery may have a significant impact on postoperative course 
and may reduce hospital stay. 
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